2VTM PDB NFT
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.
MOLNFT AF v1 smart contract in GenesisL1 blockchain:
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
IPFS of NFT metadata:
bafybeihokxc7khwgcurli7jyzfrxm63farqjkj45lhr4n2msk2vob6xqey/metadata.json
IPFS of structure file:
bafybeihfzynj2gf5mk5ul2pwhbfkzwjasjgxfvqxmz6oo6qcj3mue6dsly/2vtm.pdb
MOLNFT 2VTM research and analysis (ICN3D with VR)
FASTA sequences
>2vtm_A mol:protein length:298 CELL DIVISION PROTEIN KINASE 2
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
References and links
Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 2VTM
TITLE: Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.
DOI: 10.1021/jm800382h
AUTHORS: Wyatt, P.G., Woodhead, A.J., Boulstridge, J.A., Berdini, V., Carr, M.G., Cross, D.M., Danillon, D., Davis, D.J., Devine, L.A., Early, T.R., Feltell, R.E., Lewis, E.J., McMenamin, R.L., Navarro, E.F., O'Brien, M.A., O'Reilly, M., Reule, M., Saxty, G., Seavers, L.C.A., Smith, D., Squires, M.S., Trewartha, G., Walker, M.T., Woolford, A.J.
ACCESSION DATE: 05/15/08
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/2VTM